Evidence map›Paper›PMID 40842736›Full record

ArticleThe journal of physical chemistry. C, Nanomaterials and interfaces2025

Unraveling Plasmon-Enhanced Reactive Oxygen Species Generation through Ultrafast Light.

Ramprasath Rajagopal, Koustav Kundu, Tianhong Ouyang, Akilesh Nalluri, Gwen Liu, Lawrence D Ziegler, Shyamsunder Erramilli, Björn M Reinhard

Abstract read
In one paragraph

Article in The journal of physical chemistry. C, Nanomaterials and interfaces, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Ultrafast-light driven plasmonic inactivation ofJournal of materials chemistry. B · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ramprasath RajagopalDepartment of Physics, Boston University, Boston, MA 02215, United States.
Koustav KunduThe Photonics Center, Boston University, Boston, MA 02215, United States.
Tianhong OuyangThe Photonics Center, Boston University, Boston, MA 02215, United States.
Akilesh NalluriThe Photonics Center, Boston University, Boston, MA 02215, United States.
Gwen LiuThe Photonics Center, Boston University, Boston, MA 02215, United States.
Lawrence D ZieglerThe Photonics Center, Boston University, Boston, MA 02215, United States.
Shyamsunder ErramilliDepartment of Physics, Boston University, Boston, MA 02215, United States.
Björn M ReinhardThe Photonics Center, Boston University, Boston, MA 02215, United States.

Funding

Plasmonic Inactivation of Virus and Mycoplasma ContaminantsR01GM142012 · NIGMS · BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) · PI ERRAMILLI, SHYAMSUNDER, GUMMULURU, SURYARAM · 2021 to 2024
$1.3M
NIGMS NIH HHS R01 GM142012
6 · The paper itself

Abstract

Reactive oxygen species (ROS) generation through gold nanorods (AuNRs) excited by 812 nm centered, 85 femtosecond (fs)-pulsed laser irradiation was investigated through a rhodamine B degradation assay. The initial rate of rhodamine B fluorescence intensity degradation is determined by the rate of ROS generation, but at later time points the laser irradiation induced deformation of AuNRs reduces the rate of rhodamine B degradation. For different AuNR preparations that all had a localized surface plasmon resonance (LSPR) mode at around 800 nm but differed in size, the initial rate of rhodamine B fluorescence intensity decrease follows a trend predicted by the simulated peak near-field intensities and absorption efficiencies except for the smallest AuNRs with dimensions of 30 by 7 nm. The initial rate of ROS generation exhibits a power law dependence on the fluence. The reshaping of the AuNRs on longer timescales also depends on the fluence. For 2.3 mJ/cm

Identifiers

PMID40842736
PMCPMC12366834

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.